Clinical and biochemical characteristics of patients with acromegaly and normal or increased prolactin levels
Background: Prevalence of hyperprolactinemia in patients with acromegaly is 30 to 40%. Since recently, the necessity of screening for acromegaly in hyperprolactinemic patients with pituitary adenoma has been actively debated. The literature on this issue has been controversial, with some authors des...
Saved in:
Main Authors: | Yuliya A. Kukushkina, Irena A. Ilovayskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2024-12-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://almclinmed.ru/jour/article/viewFile/17371/1702 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of acromegaly on thyroid disease
by: Caiyan Mo, et al.
Published: (2023-11-01) -
Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
by: Chaitanya Gandhi, et al.
Published: (2025-01-01) -
Patient perspectives on acromegaly disease burden: insights from a community meeting
by: Shruti N. Shah, et al.
Published: (2025-02-01) -
Pituitary adenoma: a literature review
by: A. Sidaraitė, et al.
Published: (2018-03-01) -
Differential diagnosis of rheumatic manifestations of acromegaly. Case report
by: Margarita A. Perepelova, et al.
Published: (2024-12-01)